Toward Drug Repurposing in Epigenetics: Olsalazine as a Hypomethylating Compound Active in a Cellular Context

Publisher： John Wiley & Sons Inc

E-ISSN： 1860-7187|9|3|560-565

ISSN： 1860-7179

Source： CHEMMEDCHEM, Vol.9, Iss.3, 2014-03, pp. : 560-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Epigenetics in Drug Discovery

By  

CHEMMEDCHEM, Vol. 9, Iss. 3, 2014-03 ,pp. : 415-417

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corrigendum: Repurposing the Chemical Scaffold of the Anti‐Arthritic Drug Lobenzarit to Target Tryptophan Biosynthesis in Mycobacterium tuberculosis

By  

CHEMBIOCHEM, Vol. 16, Iss. 5, 2015-03 ,pp. : 706-706

John Wiley & Sons Inc

Access to resources Recommend Favorite

Toward a Cancer Drug of Fungal Origin

By  

MEDICINAL RESEARCH REVIEWS, Vol. 35, Iss. 5, 2015-09 ,pp. : 937-967

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phenolic Compound Diversity Explored in the Context of Photo‐Oxidative Stress Protection

By  

PHYTOCHEMICAL ANALYSIS, Vol. 29, Iss. 2, 2018-03 ,pp. : 129-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

Computational Approaches Towards the Rational Design of Drug-like Compound Libraries

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 4, Iss. 6, 2001-09 ,pp. : 453-475

Bentham Science Publishers

Access to resources Recommend Favorite